These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 37493267)

  • 1. Clinical implications of gallbladder enlargement in Kawasaki disease.
    Miyazawa A; Matsushima T; Sakakibara H; Akahoshi S; Morikawa Y; Koyama Y; Miyata K; Hataya H; Miura M
    Pediatr Int; 2023; 65(1):e15543. PubMed ID: 37493267
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sonographic gallbladder abnormality is associated with intravenous immunoglobulin resistance in Kawasaki disease.
    Chen CJ; Huang FC; Tiao MM; Huang YH; Lin LY; Yu HR; Yang KD; Huang YC; Chen CC; Chang WC; Kuo HC
    ScientificWorldJournal; 2012; 2012():485758. PubMed ID: 22792043
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk factors of immunoglobulin resistance and coronary complications in children with Kawasaki disease.
    Berdej-Szczot E; Małecka-Tendera E; Gawlik T; Firek-Pędras M; Szydłowski L; Gawlik A
    Kardiol Pol; 2017; 75(3):261-266. PubMed ID: 27995598
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Retrospective Cohort Study of Intravenous Immunoglobulin Therapy in the Acute Phase of Kawasaki Disease: The Earlier, the Better?
    Li W; He X; Zhang L; Wang Z; Wang Y; Lin H; Yuan J; Xie X; Qin Y; Huang P
    Cardiovasc Ther; 2021; 2021():6660407. PubMed ID: 34239607
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Multicenter Study of Intravenous Immunoglobulin Non-response in Kawasaki Disease.
    Wei M; Huang M; Chen S; Huang G; Huang M; Qiu D; Guo Z; Jiang J; Zhou X; Yu Q; Guo Y; Fu L; Gao W; Li F
    Pediatr Cardiol; 2015 Aug; 36(6):1166-72. PubMed ID: 25812827
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The factors affecting the disease course in Kawasaki disease.
    Arslanoglu Aydin E; Ertugrul I; Bilginer Y; Batu ED; Sonmez HE; Demir S; Arici ZS; Sag E; Alehan D; Ozen S
    Rheumatol Int; 2019 Aug; 39(8):1343-1349. PubMed ID: 31139951
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of Age, Sex, Lack of Response to Intravenous Immunoglobulin, and Development of Coronary Artery Abnormalities in Children With Kawasaki Disease in Japan.
    Takekoshi N; Kitano N; Takeuchi T; Suenaga T; Kakimoto N; Suzuki T; Kada TT; Shibuta S; Tachibana S; Murayama Y; Yamaga H; Suzuki H
    JAMA Netw Open; 2022 Jun; 5(6):e2216642. PubMed ID: 35696166
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Timing of intravenous immunoglobulin treatment and risk of coronary artery abnormalities in children with Kawasaki disease.
    Bal AK; Prasad D; Umali Pamintuan MA; Mammen-Prasad E; Petrova A
    Pediatr Neonatol; 2014 Oct; 55(5):387-92. PubMed ID: 24636168
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Z-score is a possible predictor of the risk of coronary artery lesion development in patients with Kawasaki disease in Japan.
    Suzuki T; Kakimoto N; Tsuchihashi T; Suenaga T; Takeuchi T; Shibuta S; Kitano N; Suzuki H
    Eur J Pediatr; 2021 Sep; 180(9):2797-2805. PubMed ID: 33763715
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of Genetic Polymorphisms in Kawasaki Disease with the Response to Intravenous Immunoglobulin Therapy.
    Sapountzi E; Fidani L; Giannopoulos A; Galli-Tsinopoulou A
    Pediatr Cardiol; 2023 Jan; 44(1):1-12. PubMed ID: 35908117
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neutropenia after intravenous immunoglobulin therapy is associated with coronary artery lesions in children with Kawasaki disease: a case control study.
    Wang Z; Weng F; Li C; Shi H; Tang Z; Qiu H; He Y; Wu R; Chu M
    BMC Pediatr; 2018 Feb; 18(1):76. PubMed ID: 29466965
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Infliximab Plus Intravenous Immunoglobulin (IVIG) Versus IVIG Alone as Initial Therapy in Children With Kawasaki Disease Presenting With Coronary Artery Lesions: Is Dual Therapy More Effective?
    Jone PN; Anderson MS; Mulvahill MJ; Heizer H; Glodé MP; Dominguez SR
    Pediatr Infect Dis J; 2018 Oct; 37(10):976-980. PubMed ID: 29461447
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reevaluation of the efficacy of intravenous gammaglobulin in the prevention and treatment of coronary artery lesion in Kawasaki disease.
    Qin L; Saumu MT; Wang H; Shi H; Hu X; Cheng P
    J Huazhong Univ Sci Technolog Med Sci; 2005; 25(3):348-50, 370. PubMed ID: 16201293
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association between maternal age and outcomes in Kawasaki disease patients.
    Huang WD; Lin YT; Tsai ZY; Chang LS; Liu SF; Lin YJ; Kuo HC
    Pediatr Rheumatol Online J; 2019 Jul; 17(1):46. PubMed ID: 31324255
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Risk Prediction of Coronary Artery Lesions through the Novel Hematological Z-Values in 4 Chronological Age Subgroups of Kawasaki Disease.
    Cho HJ; Kim WY; Park SM; Lee JH; Shin HJ; Jang GY; Ha KS
    Medicina (Kaunas); 2020 Sep; 56(9):. PubMed ID: 32932823
    [No Abstract]   [Full Text] [Related]  

  • 16. Predictive value of monocyte to HDL-C ratio for coronary artery lesions and intravenous immunoglobulin resistance in Kawasaki disease.
    Wang JR; Zhao HZ; Chang LJ; Xu X; Gao Y; Li M; Kong QY; Wang MM; Zhao CF
    Eur J Pediatr; 2023 Oct; 182(10):4399-4406. PubMed ID: 37480545
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identifying Kawasaki Disease With a Low Coronary Artery Aneurysm Risk.
    Iio K; Morikawa Y; Miyata K; Kaneko T; Misawa M; Yamagishi H; Miura M
    Pediatr Infect Dis J; 2023 Jul; 42(7):608-613. PubMed ID: 37053581
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Facial nerve palsy may indicate coronary artery lesions in Kawasaki disease.
    Chen J; Liu P; Hu W; Xu Y; Deng J
    Clin Rheumatol; 2021 Oct; 40(10):4191-4197. PubMed ID: 34059986
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Coronary artery status of patients with transient fever 24-36 h after first IVIG infusion did not differ from that seen in responsive patients.
    Baek JS; Yu JJ; Kim MJ; You J; Jun HO; Kim YH; Ko JK
    Pediatr Rheumatol Online J; 2018 Dec; 16(1):83. PubMed ID: 30594188
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Refractory Kawasaki disease: modified methylprednisolone regimen decreases coronary artery dilatation.
    Zhang M; Zheng Y; Li X; Yang S; Shi L; Li A; Liu Y
    Pediatr Res; 2022 May; 91(6):1542-1550. PubMed ID: 34021270
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.